(Q46611566)

English

Time course of depression-symptom improvement during treatment with duloxetine

scientific article published in January 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

0 references

Time course of depression-symptom improvement during treatment with duloxetine (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

author name string

Robert M A Hirschfeld

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

Craig Mallinckrodt

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

Thomas C Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

Michael J Detke

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

21

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

170-177

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

21 January 2018

LY248686, a new inhibitor of serotonin and norepinephrine uptake

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

21 January 2018

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of duloxetine on painful physical symptoms associated with depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Accounting for dropout bias using mixed-effects models.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability and adherence issues in antidepressant therapy

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of Onset of Antidepressant Response With Fluoxetine Treatment

1 reference

https://api.crossref.org/works/10.1002%2FDA.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.20071

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16035056

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46611566&oldid=2122203519"